News
PGNY
26.16
+0.65%
0.17
Progyny (PGNY): Evaluating Whether Recent Share Price Momentum Still Leaves Upside in Its Valuation
Simply Wall St · 1d ago
Progyny President’s Employment to End December 2025
TipRanks · 1d ago
Progyny Inc. Awards $250,000 Annual Advisory Fee to Outgoing President Under New Consulting Agreement
Reuters · 1d ago
3 Healthcare Stocks We’re Skeptical Of
Barchart · 1d ago
Progyny CFO Mark S. Livingston Reports Sale of Common Shares
Reuters · 3d ago
Progyny (PGNY) Upgraded to Buy: Here's What You Should Know
NASDAQ · 3d ago
Weekly Report: what happened at PGNY last week (1208-1212)?
Weekly Report · 3d ago
Progyny (PGNY): Revisiting Valuation After a 10% Monthly Rally and 57% One-Year Share Price Surge
Simply Wall St · 12/09 23:28
Progyny Initiated at Overweight by Barclays
Dow Jones · 12/09 16:23
Using Quantitative Signal Data For Portfolio Management
Seeking Alpha · 12/09 09:20
Progyny Inc. EVP and General Counsel Allison Swartz Reports Disposal of Common Shares
Reuters · 12/08 21:23
2026 Market Outlook: S&P 500 To 7600, Healthcare, Renewable Energy, Industrials Will Lead
Seeking Alpha · 12/08 19:55
Weekly Report: what happened at PGNY last week (1201-1205)?
Weekly Report · 12/08 09:21
2 Stocks Under $50 on Our Watchlist and 1 We Find Risky
Barchart · 12/08 03:52
Has Progyny’s 62.7% Surge Outrun Its Fundamentals in 2025?
Simply Wall St · 12/06 05:19
Progyny CFO Mark S. Livingston Reports Disposal of Common Shares
Reuters · 12/04 21:18
3 Hyped Up Stocks Walking a Fine Line
Barchart · 12/04 04:56
First Week of January 2026 Options Trading For Progyny (PGNY)
NASDAQ · 12/03 15:39
CEO Peter Anevski Buys $1.9 Million of Progyny Stock: Should Investors Buy Too?
NASDAQ · 12/02 23:16
Progyny EVP and General Counsel Allison Swartz Reports Sale of Common Shares
Reuters · 12/02 21:16
More
Webull provides a variety of real-time PGNY stock news. You can receive the latest news about Progyny, Inc. through multiple platforms. This information may help you make smarter investment decisions.
About PGNY
Progyny, Inc. is a benefit management company. The Company specializes in fertility and family building benefits solutions in the United States. The Company’s clients include various employers across an array of industries. It has contracts to provide coverage to approximately 6.7 million employees and their partners (known as members). The Company provides its benefits through its proprietary Smart Cycle approach. Smart Cycles include the medical services required for a member’s full course of treatment, including all necessary diagnostic testing and access to the technology. In addition to its fertility benefits solution, the Company offers an integrated pharmacy benefits solution, Progyny Rx, which can be added by its clients. Progyny Rx provides its members with access to the medications needed during their fertility treatment. It provides care management services, as well as medication administration training, pharmacy support services and continuing patient care advocate support.